Trump administration readies new tariffs on select drugmakers, Bloomberg News reports
Trump administration readies new tariffs on select drugmakers, Bloomberg News reports
ReutersWed, April 1, 2026 at 11:39 PM UTC
0
1 / 0U.S. President Donald Trump unveils the TrumpRx drug discount siteU.S. President Donald Trump speaks during an event to unveil the TrumpRx drug discount site, in the South Court Auditorium on the White House campus, in Washington, D.C., U.S., February 5, 2026. REUTERS/Al Drago
April 1 (Reuters) - The Trump administration is set to announce tariffs as soon as Thursday on drugmakers that have not struck deals guaranteeing low prices in the U.S., Bloomberg News reported on Wednesday, citing people familiar with the plan.
The White House did not immediately respond to Reuters' request for comment.
The Trump administration has been considering a 100% tariff on imported branded and patented medicines, prompting global drugmakers to ramp up U.S. manufacturing and stockpile inventory.
Advertisement
Pfizer and AstraZeneca have secured multi-year tariff exemptions through pricing deals and commitments to the new TrumpRx.gov platform. Eli Lilly, Johnson & Johnson and Merck have pledged billions to expand U.S. operations to avoid penalties.
Companies that do not have agreements and are not in negotiations with the administration will be subject to 100% tariffs, the report said.
The plans are not final and could still change, and there could also be exemptions for some medicines and disease categories, it said.
(Reporting by Fabiola Arámburo in Mexico City; Editing by Chris Reese)
Source: “AOL General News”
